Augelli-Szafran C E, Blankley C J, Jaen J C, Moreland D W, Nelson C B, Penvose-Yi J R, Schwarz R D, Thomas A J
Departments of Medicinal Chemistry and Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA.
J Med Chem. 1999 Feb 11;42(3):356-63. doi: 10.1021/jm980067l.
A series of esters of 1,4-disubstituted tetrahydropyridine carboxylic acids (I) has been synthesized and characterized as potential m1 selective muscarinic receptor antagonists. The affinity of these compounds for the five human muscarinic receptor subtypes (Hm1-Hm5) was determined by the displacement of [3H]-NMS binding using membranes from transfected Chinese hamster ovarian cells. One of the most potent and selective compounds of this series is an analogue of I [11, R1 = (CH2)5CH3], which has an IC50 value of 27.3 nM at the m1 receptor and possesses 100-fold (m2), 48-fold (m3), 74-fold (m4), and 19-fold (m5) selectivities at the other receptors. Thus, this analogue appears to be more selective on the basis of binding than the prototypical m1 antagonist, pirenzepine. Functional data, such as the inhibition of carbachol-stimulated phosphatidylinositol hydrolysis, on selected analogues confirmed the muscarinic antagonistic properties of this chemical series.
一系列1,4 - 二取代四氢吡啶羧酸(I)的酯类化合物已被合成并表征为潜在的m1选择性毒蕈碱受体拮抗剂。使用转染的中国仓鼠卵巢细胞的膜,通过[3H] - NMS结合的置换来测定这些化合物对五种人类毒蕈碱受体亚型(Hm1 - Hm5)的亲和力。该系列中最有效和最具选择性的化合物之一是I [11, R1 = (CH2)5CH3]的类似物,其在m1受体处的IC50值为27.3 nM,在其他受体处具有100倍(m2)、48倍(m3)、74倍(m4)和19倍(m5)的选择性。因此,基于结合情况,该类似物似乎比原型m1拮抗剂哌仑西平更具选择性。对选定类似物的功能数据,如对卡巴胆碱刺激的磷脂酰肌醇水解的抑制作用,证实了该化学系列的毒蕈碱拮抗特性。